It was an honor to testify before the U.S. Senate Appropriations Subcommittee on Labor, Health and Human Services, Education, and Related Agencies on July 2. The topic of the hearing was the President’s plan to develop and distribute a COVID-19 vaccine. Also testifying were Robert Redfield, director of the Centers for Disease Control and Prevention, and Gary Disbrow, acting director of Biomedical Advanced Research and Development Authority (BARDA). The nearly three-hour hearing allowed a productive exchange of information on this critical topic and many of NIH’s high-priority efforts to develop vaccines and therapeutics for COVID-19. Credit: C-Span.
Dr. Robert Redfield (second left), director of the Centers for Disease Control and Prevention, visited NIH on June 12, 2018. Joining me in welcoming him are James Gilman, first chief executive officer for the NIH Clinical Center (left) and Anthony Fauci (right), director of NIH’s National Institute of Allergy and Infectious Diseases. Credit: NIH
